Evolus's top three insider shareholders as of September 09, 2026 are Inc. Medytox (Other, 3.38Mn shares), Inc. Medytox (Other, 3.38Mn shares), Vikram Malik (Director, 1.14Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Inc. Medytox | Other | 3,381,326 | 0 | 3,381,326 | 58.4% | 18 Oct, 2023 |
| 2 | David Moatazedi | Director, Officer | 499,592 | 0 | 499,592 | 8.6% | 04 Sep, 2026 |
| 3 | Rui Avelar | Officer | 427,423 | 0 | 427,423 | 7.4% | 20 Mar, 2026 |
| 4 | Vikram Malik | Director | 321,109 | 0 | 321,109 | 5.5% | 19 Feb, 2026 |
| 5 | Tatjana Mitchell | Chief Financial Officer | 226,092 | 0 | 226,092 | 3.9% | 19 Feb, 2026 |
| 6 | Sandra Beaver | Chief Financial Officer | 167,089 | 0 | 167,089 | 2.9% | 14 May, 2025 |
| 7 | Lauren P Silvernail | Officer | 141,571 | 0 | 141,571 | 2.4% | 18 May, 2022 |
| 8 | Crystal Muilenburg | Chief Marketing Officer | 134,248 | 0 | 134,248 | 2.3% | 10 Mar, 2022 |
| 9 | Brady Stewart | Director | 134,188 | 0 | 134,188 | 2.3% | 19 Feb, 2026 |
| 10 | Albert G Iii White | Director | 95,937 | 0 | 95,937 | 1.7% | 19 Feb, 2026 |
| 11 | Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0 | 89,949 | 1.6% | 26 Aug, 2025 |
| 12 | Simone Blank | Director | 77,111 | 0 | 77,111 | 1.3% | 11 Mar, 2025 |
| 13 | Robert Hayman | Director | 54,856 | 0 | 54,856 | 0.9% | 09 Feb, 2024 |
| 14 | Peter C Farrell | Director | 43,174 | 0 | 43,174 | 0.7% | 31 Jan, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Sep, 2026 | David Moatazedi | Director, Officer | Disposed S | 105,108 | $9.04 | $950.02K | 499,592 | Direct |
| 20 Mar, 2026 | David Moatazedi | Director, Officer | Disposed S | 13,669 | $4.75 | $64.93K | 604,700 | Direct |
| 20 Mar, 2026 | Rui Avelar | Officer | Disposed S | 3,119 | $4.75 | $14.82K | 427,423 | Direct |
| 16 Mar, 2026 | David Moatazedi | Director, Officer | Acquired M | 67,489 | $0.00 | $0 | 735,089 | Direct |
| 16 Mar, 2026 | Rui Avelar | Officer | Acquired M | 8,804 | $0.00 | $0 | 460,538 | Direct |
| 17 Mar, 2026 | David Moatazedi | Director, Officer | Disposed S | 116,720 | $4.89 | $570.56K | 618,369 | Direct |
| 17 Mar, 2026 | Rui Avelar | Officer | Disposed S | 29,996 | $4.89 | $146.63K | 430,542 | Direct |
| 16 Mar, 2026 | Rui Avelar | Officer | Disposed M | 8,804 | $0.00 | $0 | 8,802 | Direct |
| 16 Mar, 2026 | David Moatazedi | Director, Officer | Disposed M | 67,489 | $0.00 | $0 | 67,488 | Direct |
| 17 Feb, 2026 | Albert G Iii White | Director | Acquired A | 45,559 | $0.00 | $0 | 95,937 | Direct |
| 17 Feb, 2026 | Brady Stewart | Director | Acquired A | 45,559 | $0.00 | $0 | 134,188 | Direct |
| 17 Feb, 2026 | David Moatazedi | Director, Officer | Acquired A | 313,212 | $0.00 | $0 | 667,600 | Direct |
| 17 Feb, 2026 | Vikram Malik | Director | Acquired A | 45,559 | $0.00 | $0 | 321,109 | Direct |
| 17 Feb, 2026 | Vikram Malik | Director | Acquired A | 45,559 | $0.00 | $0 | 321,109 | Direct |
| 17 Feb, 2026 | Tatjana Mitchell | Chief Financial Officer | Acquired A | 121,489 | $0.00 | $0 | 226,092 | Direct |
| 17 Feb, 2026 | Tatjana Mitchell | Chief Financial Officer | Acquired A | 121,489 | $0.00 | $0 | 226,092 | Direct |
| 17 Feb, 2026 | Albert G Iii White | Director | Acquired A | 45,559 | $0.00 | $0 | 95,937 | Direct |
| 17 Feb, 2026 | Brady Stewart | Director | Acquired A | 45,559 | $0.00 | $0 | 134,188 | Direct |
| 17 Feb, 2026 | Albert G Iii White | Director | Acquired A | 45,559 | $0.00 | $0 | 95,937 | Direct |
| 17 Feb, 2026 | Rui Avelar | Officer | Acquired A | 94,913 | $0.00 | $0 | 451,734 | Direct |